Clinical Trial Update: Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias [NA]

View source ↗

Summary

A completed clinical trial comparing transdermal radiofrequency V ERASER with polidocanol sclerotherapy for reticular veins and telangiectasias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Telangiectasia
• Varicose Veins

Drugs mentioned

• polidocanol (polidocanol)

Snippet

Sponsor: Science Valley Research Institute | Conditions: Varicose Veins Leg, Telangiectasias | NA | Status: COMPLETED